Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36224722)

  • 1. Exosomal epidermal growth factor receptor is involved in HPV-16 E7-induced epithelial-mesenchymal transition of non-small cell lung cancer cells: A driver of signaling in vivo.
    Zhou Z; Wu X; Zhan R; Li X; Cheng D; Chen L; Wang T; Yu H; Zhang G; Tang X
    Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 36224722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal EGFR and miR-381-3P Mediate HPV-16 E7 Oncoprotein-Induced Angiogenesis of Non-Small Cell Lung Cancer.
    Zhan R; Yu H; Zhang G; Ding Q; Li H; Li X; Tang X
    Front Biosci (Landmark Ed); 2024 May; 29(5):189. PubMed ID: 38812317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Epithelial-Mesenchymal Transition via STAT3 Signaling Pathway in Non-Small Cell Lung Cancer Cells.
    Zhang W; Wu X; Hu L; Ma Y; Xiu Z; Huang B; Feng Y; Tang X
    Oncol Res; 2017 May; 25(5):843-852. PubMed ID: 28508744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of monoamine oxidase A in HPV-16 E7-induced epithelial-mesenchymal transition and HIF-1α protein accumulation in non-small cell lung cancer cells.
    Huang B; Zhou Z; Liu J; Wu X; Li X; He Q; Zhang P; Tang X
    Int J Biol Sci; 2020; 16(14):2692-2703. PubMed ID: 32792865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-derived miR-210 involved in resistance to osimertinib and epithelial-mesenchymal transition in EGFR mutant non-small cell lung cancer cells.
    Hisakane K; Seike M; Sugano T; Yoshikawa A; Matsuda K; Takano N; Takahashi S; Noro R; Gemma A
    Thorac Cancer; 2021 Jun; 12(11):1690-1698. PubMed ID: 33939301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs.
    Ahmad A; Maitah MY; Ginnebaugh KR; Li Y; Bao B; Gadgeel SM; Sarkar FH
    J Hematol Oncol; 2013 Oct; 6(1):77. PubMed ID: 24199791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK Signaling Pathway Is Involved in HPV-16 E6 but not E7 Oncoprotein-Induced HIF-1α Protein Accumulation in NSCLC Cells.
    Liu F; Lin B; Liu X; Zhang W; Zhang E; Hu L; Ma Y; Li X; Tang X
    Oncol Res; 2016; 23(3):109-18. PubMed ID: 26931433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway.
    Yang F; Yan Y; Yang Y; Hong X; Wang M; Yang Z; Liu B; Ye L
    Cell Signal; 2020 Sep; 73():109675. PubMed ID: 32446904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells.
    Zhang E; Feng X; Liu F; Zhang P; Liang J; Tang X
    PLoS One; 2014; 9(7):e103440. PubMed ID: 25058399
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hu C; Zhou A; Hu X; Xiang Y; Huang M; Huang J; Yang D; Tang Y
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/Akt/HIF-1α signaling pathway mediates HPV-16 oncoprotein-induced expression of EMT-related transcription factors in non-small cell lung cancer cells.
    Liu J; Huang B; Xiu Z; Zhou Z; Liu J; Li X; Tang X
    J Cancer; 2018; 9(19):3456-3466. PubMed ID: 30310502
    [No Abstract]   [Full Text] [Related]  

  • 13. microRNA-204 shuttled by mesenchymal stem cell-derived exosomes inhibits the migration and invasion of non-small-cell lung cancer cells via the KLF7/AKT/HIF-1α axis.
    Liu XN; Zhang CB; Lin H; Tang XY; Zhou R; Wen HL; Li J
    Neoplasma; 2021 Jul; 68(4):719-731. PubMed ID: 33847133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.
    Yue J; Lv D; Wang C; Li L; Zhao Q; Chen H; Xu L
    Oncogene; 2018 Aug; 37(31):4300-4312. PubMed ID: 29717264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes secreted by metastatic cancer cells promotes epithelial mesenchymal transition in small cell lung carcinoma: The key role of Src/TGF-β1 axis.
    Shen Y; TanTai J
    Gene; 2024 Jan; 892():147873. PubMed ID: 37832808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal LRG1 promotes non-small cell lung cancer proliferation and metastasis by binding FN1 protein.
    Wu H; Zeng C; Wu G; Fang F; Xiao C; Li L; Luo Y; Ouyang Z; Zhou C; Qian Y
    Exp Cell Res; 2024 Jun; 439(2):114097. PubMed ID: 38796135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
    Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
    Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.